Oyster Point Pharma, Inc. Current Assets
Oyster Point Pharma, Inc. had Current Assets of $97.71 million as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2022-11-10
- 2022-09-30: Assets, Current $97.71M.
- 2022-06-30: Assets, Current $132.72M.
- 2022-03-31: Assets, Current $167.35M.
- 2021-12-31: Assets, Current $215.25M.
| Period end | Assets, Current |
|---|---|
| 2022-09-30 | $97.71M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $132.72M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $167.35M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $215.25M 10-Q · filed 2022-11-10 |
| 2021-09-30 | $189.69M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $158.89M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $182.65M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $196.37M 10-K · filed 2022-02-24 |
| 2020-09-30 | $215.19M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $228.56M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $131.02M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $142.18M 10-K · filed 2021-02-18 |
| 2019-09-30 | $76.89M 10-Q · filed 2019-12-03 |
| 2018-12-31 | $5.62M 10-K · filed 2020-02-27 |